Orissa HC seeks government response on advanced blood testing technology in Odisha

Cuttack: Orissa high court on Wednesday sought a response from the state govt on a PIL seeking implementation of advanced Individual Donor Nucleic Acid Testing (ID-NAT) in all govt-run and affiliated blood banks across Odisha.

The division bench, led by Chief Justice Harish Tandon and Justice M S Raman heard the petition filed by Dr Amarendra Mohapatra, a 64-year-old retired scientist of Indian Council of Medical Research’s Regional Medical Research Centre, Bhubaneswar.

The petitioner urged the state to procure and install ID-NAT systems through the Odisha State Medical Corporation Ltd, replacing the currently used NAT-PCR technology, which he termed as outdated and less effective in detecting infections like HIV, HBV and HCV.

The PIL contended that ID-NAT provides more accurate and timely detection of blood-borne infections and has been adopted by institutions like AIIMS Delhi, AIIMS Rishikesh, AIIMS Bhubaneswar and ILBS Delhi.

Advocate Satya Sundar Kanungo appeared for the petitioner, while additional govt advocate Debasish Tripathy represented the state. The matter was adjourned to Sept 15.

Advanced Individual Donor-Nucleic Acid Testing (ID-NAT) is a highly sensitive molecular technique that directly detects the viral DNA or RNA of infectious agents like HIV, Hepatitis B (HBV), and Hepatitis C (HCV) in individual blood donor samples. This method significantly reduces the “window period” – the time between exposure to a virus and the development of detectable antibodies or antigens – thereby providing a crucial additional layer of safety to the blood supply by detecting infections earlier than traditional serological (antibody/antigen) tests.

Related Posts

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

New Delhi: Serious legal gaps in the Drugs and Cosmetics Act, 1940, combined with acute shortages of manpower and infrastructure, continue to impede the Central Drugs Standard Control Organisation (CDSCO)…

Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

Patna: In a significant ruling that could have far-reaching implications for NDPS drug-related prosecutions involving common pharmaceutical compounds, the Patna High Court has held that Phenothiazine and Promethazine do not…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

COMT Inhibitors May Fuel Gut Bacteria That Degrade Levodopa In Parkinson’s Patients

COMT Inhibitors May Fuel Gut Bacteria That Degrade Levodopa In Parkinson’s Patients

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

IPC releases draft NFI-2026 to promote rational use of medicines

IPC releases draft NFI-2026 to promote rational use of medicines